Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - COST OF REVENUE
Cost of Revenue UTHR - United Therapeutics Corporation
258 M
LAST VALUE
44.98%
2 YEAR CAGR
5.32%
5 YEAR CAGR
6.98%
10 YEAR CAGR